Search filters

List of works by Niels Vande Casteele

A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis

scientific article

A product review of vedolizumab in inflammatory bowel disease

scientific article published on 07 May 2019

Additional Stability Testing of Cryopreserved Intestinal Biopsies for Downstream Flow Cytometric Analysis

scientific article published on 08 September 2018

American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases.

scientific article published on 31 July 2017

An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel Diseases

scientific article published on September 2015

An update on anti-TNF agents in ulcerative colitis

scientific article

Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial

scientific article published on 10 April 2015

Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient

article

Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results

scientific article published on 14 May 2016

Assays for measurement of TNF antagonists in practice.

scientific article published on 8 March 2016

Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis

article

Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation

scientific article

Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study

scientific article published on 08 December 2015

Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease

scientific article published on 12 January 2018

Clinical Pharmacology in Adult and Pediatric Inflammatory Bowel Disease

scientific article published on 01 November 2018

Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial

scientific article published on 27 April 2017

Customized Use of Anti-Tumour Necrosis Factor-α Therapy During Pregnancy

scientific article published on 01 November 2018

Definitions of response and remission for the Robarts Histopathology Index

scientific article published on 26 October 2018

Detection of infliximab levels and anti-infliximab antibodies: a comparison of three different assays

scientific article published on 28 August 2012

Development of a universal anti-adalimumab antibody standard for interlaboratory harmonization

scientific article

Early serial trough and antidrug antibody level measurements predict clinical outcome of infliximab and adalimumab treatment: Table 1

article

Early trough levels and antibodies to infliximab predict safety and success of reinitiation of infliximab therapy

scientific article published on 29 January 2014

Editorial: assessing histological disease activity in Crohn's disease-a call for standardisation of mucosal biopsy location. Authors' reply

scientific article published on 01 July 2019

Editorial: variability in adalimumab trough and peak serum concentrations

scientific article

Efficacy and Safety Profile of Anti-tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn's Disease: A Network Meta-analysis of Indirect Comparisons

scientific article

Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease

scientific article published on 24 April 2020

Efficient Early Drug Development for Ulcerative Colitis

scientific article published on 24 March 2016

Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview

scientific article

Evaluation of optimal biopsy location for assessment of histological activity, transcriptomic and immunohistochemical analyses in patients with active Crohn's disease

scientific article published on 15 April 2019

Evaluation of the effect of storage condition on cell extraction and flow cytometric analysis from intestinal biopsies

scientific article published on 01 June 2018

Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease

scientific article

Factors Influencing Drug Disposition of Monoclonal Antibodies in Inflammatory Bowel Disease: Implications for Personalized Medicine

scientific article published on 01 October 2019

Fecal calprotectin-guided dosing of mesalamine in ulcerative colitis: concept proved but more data needed

scientific article

Heterogeneity in Definitions of Efficacy and Safety Endpoints for Clinical Trials of Crohn's Disease: A Systematic Review for Development of a Core Outcome Set.

scientific article published on 26 March 2018

High Anti-Tumour Necrosis Factor Trough Concentrations--Only a Cost Issue or Also Hidden Dangers Ahead?

scientific article published on 7 September 2015

IBD: Indication extrapolation for anti-TNF biosimilars

scientific article

Immunogenicity to infliximab is associated with HLA-DRB1.

scientific article published on 15 April 2015

Incidence of acute severe infusion reactions to infliximab depends on definition used rather than assay

scientific article published on 01 August 2011

Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.

scientific article

Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease.

scientific article published on 5 April 2018

JAK-STAT pathway targeting for the treatment of inflammatory bowel disease

scientific article published on 19 March 2020

Letter: combination of biologics in inflammatory bowel diseases. Authors' reply

scientific article published on 01 August 2020

Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' reply

scientific article published in January 2013

Letter: dose optimising infliximab in acute severe ulcerative colitis - authors' reply.

scientific article published in April 2017

Letter: dry blood spots for anti-TNF treatment monitoring in IBD

scientific article published on 01 May 2013

Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab.

scientific article

Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission

scientific article published on 3 December 2014

Mucosal Healing and Long-term Outcomes of Patients With Inflammatory Bowel Diseases Receiving Clinic-based vs Trough Concentration-based Dosing of Infliximab

scientific article

Non-Invasive Targeted Crohn’s Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring

scientific article published on 06 June 2021

Obesity and response to anti-tumor necrosis factor-α agents in patients with select immune-mediated inflammatory diseases: A systematic review and meta-analysis.

scientific article

Pharmacokinetics of anti-TNF monoclonal antibodies in inflammatory bowel disease: Adding value to current practice

scientific article

Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease

scientific article published on 01 October 2018

Preemptive Dose Optimization Using Therapeutic Drug Monitoring for Biologic Therapy of Crohn's Disease: Avoiding Failure While Lowering Costs?

scientific article published on 28 April 2015

Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis

scientific article published on 22 November 2019

Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis

article

Putting Out the Fire in Acute Kawasaki Disease.

scientific article published on 23 January 2018

Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation

scientific article published on 8 December 2016

Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial

scientific article published on 03 August 2018

Review article: dose optimisation of infliximab for acute severe ulcerative colitis

scientific article

Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse

scientific article

Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease

scientific article published on 15 November 2018

Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study.

scientific article

Similar Pharmacokinetics of Three Dosing Regimens Comprising Two Oral Delayed-Release Mesalamine Formulations in Healthy Adult Volunteers: Randomised, Open-Label, Parallel-Group Study

scientific article published on 15 July 2020

Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases

scientific article published on 04 September 2019

Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease

scientific article published on 23 May 2019

Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis

scientific article published on 25 April 2018

The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile

scientific article

The effects of pregnancy on the pharmacokinetics of infliximab and adalimumab in inflammatory bowel disease

scientific article published on 20 March 2017

The emerging role of histologic disease activity assessment in ulcerative colitis

scientific article published on 22 August 2018

The expanding therapeutic armamentarium for inflammatory bowel disease: how to choose the right drug(s) for our patients?

scientific article published on 25 August 2017

Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window

scientific article

Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

scientific article

Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives

scientific article published on April 2014

Thromboembolism as an important complication of inflammatory bowel disease

scientific article published on 01 January 2016

Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease

scientific article published on 24 February 2015

Use of Precision Medicine in Clinical Trials in Inflammatory Bowel Disease

scientific article published on 01 January 2019

Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.

scientific article published on 25 July 2014

Paulina is supported by:

About Paulina

Help